Diversity of Breast Carcinoma: Epidemiology and Histological Subtypes in Eastern India
DOI:
https://doi.org/10.37506/zxy39a02Keywords:
Breast Carcinoma, Epidemiology, Histological Subtypes, Eastern IndiaAbstract
Background: Breast cancer is the commonest malignancy among women globally. The aims of our study were to evaluate the diversity and epidemiology of breast cancer on patients admitted in Burdwan Medical College and Hospital for elective mastectomy for carcinoma breast. Materials and methods: All the patients suspected of breast malignancy were clinically evaluated with age>25 years (as breast cancer is common beyond this age) and were included in the study. All the mastectomy specimens sent to Department of Pathology, Burdwan Medical College & Hospital, for histopathological examination were considered in the study. Results: The range of patients presenting with breast cancer was between 30-65 years, while 29 patients were below the age of 50 years and 17 above it. Maximum nos of case were between 40-49 years. Among the histopathological types of the tumours, IDC NOS constituted 40 cases (86.9%), invasive lobular carcinoma constituted 2 cases (4.3%), medullary carcinoma 2 cases (4.3%), invasive papillary carcinoma and mucinous carcinoma 1 case each (2.2%). T1 (size < 2 cm) was observed in 2 cases (4.3%), T2 (size 2-5 cm) was observed in 10 cases (21.7%). T3 (size > 5cm) was seen in 5 cases (10.9%), T4 (tumour of any size with fixity to the chest wall or skin) was observed in 29 cases (63%). Grading of 42 cases was done and only 1 case (2.4%) of Grade I was seen, whereas 25 cases (59.5%) belonged to Grade II, and 16 cases (38.1%) to Grade III. Out of the 46 cases, Stage IIA constituted 8 cases (17.4%), Stage IIB 3 cases (6.5%), Stage IIIA 6 cases (13%), and Stage IIIB 29 cases (63%). Conclusion: The government needs to urgently strengthen and augment the existing facilities including screening, which is inadequate at present to handle the current breast cancer load in India, especially Eastern India.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F.
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality
Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–249.
DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J
Clin. 2011;61:409–418.
Saxena S, Szabo CI, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G, Goldgar DE,
Bhatanager D. BRCA1 and BRCA2 in Indian breast cancer patients. Hum
Mutat. 2002;20:473–474.
International Agency for Research on Cancer. India Source: Globocan 2020. [cited 11
June 2021]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/356-
india-fact-sheets.pdf . [accessed on 11 September 2023]
Mehrotra R, Yadav K. Breast cancer in India: Present scenario and the challenges
ahead. World J Clin Oncol. 2022 Mar 24;13(3):209-218. doi:
5306/wjco.v13.i3.209. PMID: 35433294; PMCID: PMC8966510.
Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr
Oncol. 2012 Jan;33(1):7-12. doi: 10.4103/0971-5851.96961. PMID: 22754202;
PMCID: PMC3385284.
Alkabban FM, Ferguson T. Breast Cancer. [Updated 2022 Sep 26]. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK482286/[accessed on 11 September 2023]
Clark BZ, Onisko A, Assylbekova B, Li X, Bhargava R, Dabbs DJ. Breast cancer
global tumor biomarkers: a quality assurance study of intratumoral
heterogeneity. Mod Pathol. 2019 Mar;32(3):354-366.
Yersal O, Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic
implications. World J Clin Oncol. 2014 Aug 10;5(3):412-24. doi:
5306/wjco.v5.i3.412. PMID: 25114856; PMCID: PMC4127612.
Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br
J Cancer 1957;11:359–377.
Nottingham or Bloom-Richardson (BR) Score/Grade.
https://staging.seer.cancer.gov/cs/input/02.05.50/breast/ssf7/?version=/tnm/home/1.7//[ac
cessed on 11 September 2023]
Hussain MA, Ali S, Tyagi SP, Reza H. Incidence of breast cancer at Aligarh. J Indian
Med Asso. 1994 September; 92(9): 296-7.
Panjwani P, Epari S, Karpate A, Shrisat H, Rajshekharan P, Basak R, et al.
Assessment of HER-2/neu status in breast cancer using fluorescence in situ
hybridization & immunohistochemistry: Experience of a tertiary cancer referral centre
in India. Indian J Med Res 2010 September; 132: 287-294.
Perez EA, Lerzo G, Pivot X, Thomas E, Vahdat L, Bosserman L, Viens P, Cai C,
Mullaney B, Peck R, Hortobagyi GN. Efficacy and safety of ixabepilone (BMS-
in a phase II study of patients with advanced breast cancer resistant to an
anthracycline, a taxane, and capecitabine. J Clin Oncol. 2007 Aug 10;25(23):3407-14.
Berg JW, Hutter R VP. Breast cancer. Cancer. 1995; 75: 257-269.
Ahmad Z, Khurshid A, Qureshi A, Idress R, Asghar N, Kayani N. Breast carcinoma
grading, estimation of tumor size, axillary lymph node status, staging, and nottingham
prognostic index scoring on mastectomy specimens. Indian J Pathol Microbiol. 2009
Oct-Dec;52(4):477-81.
Le Doussal V, Tubiana-Hulin M, Hacene K, Friedman S, Brunet M. Nuclear
characteristics as indicators of prognosis in node negative breast cancer patients.
Breast Cancer Research and Treatment. 1989 November; 14(2): 207-216.
Saleh F, Abdeen S. Pathobiological features of breast tumours in the State of Kuwait:
a comprehensive analysis. J Carcinog. 2007 Sep 24;6:12.
Al-Dujaily ES. Pathological Study of Breast Cancer By Application of Epidermal
Growth Factor Receptor Type II(HER-2/neu) (Immunohistochemical study) a thesis.
Aziz SA, Pervez S, Khan S, Kayani N, Azam SI, Rahbar MH. Significance of
immunohistochemical c-ErbB-2 product localisation pattern for prognosis in human
breast cancer. Pathol Oncol Res. 2001;7(3):190-6.
Rashed MM, Ragab MN, Galal KM. The association of HER-2/neu overexpression in
relation with p53 nuclear accumulation, hormonal receptor status and common
clinicopathological prognostic parameters in a series of Egyptian women with
incvasive ductal carcinoma. Eur J Gen Med 2007; 4: 73-79.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en